CAS: 2220162-06-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | NMDAR antagonist 1 REF: IN-DA01KL19CAS: 2220162-06-9 | 97% | A consultar | Lun 13 Ene 25 |
 | NMDAR antagonist 1 REF: TM-T5522CAS: 2220162-06-9 | 98% | 50,00 €~724,00 € | Mar 21 Ene 25 |
 | NMDAR antagonist 1 REF: 3D-VND16206CAS: 2220162-06-9 | Min. 95% | A consultar | Lun 24 Feb 25 |
NMDAR antagonist 1
CAS:2220162-06-9
Fórmula:
C20H20BrN3O2
Pureza:
97%
Forma y color:
Solid
Peso molecular:
414.2957
Ref: IN-DA01KL19
| 1mg | 101,00 € | ||
| 5mg | 207,00 € | ||
| 10mg | 467,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025
NMDAR antagonist 1
CAS:2220162-06-9
NMDAR antagonist 1 is an orally active, NR2B-selective NMDAR antagonist.
Fórmula:
C20H20BrN3O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
414.3
Ref: TM-T5522
| 1mg | 50,00 € | ||
| 5mg | 99,00 € | ||
| 10mg | 156,00 € | ||
| 25mg | 290,00 € | ||
| 50mg | 413,00 € | ||
| 100mg | 547,00 € | ||
| 200mg | 724,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
NMDAR antagonist 1
CAS:2220162-06-9
NMDAR antagonist 1 is a potent and selective NMDAR antagonist that has been shown to …
Fórmula:
C20H20BrN3O2
Pureza:
Min. 95%
Peso molecular:
414.3 g/mol
Ref: 3D-VND16206
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 24 de Febrero de 2025
